i.ndiaye
Submits third-party assay reports on material purchased directly. Based in Essen.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.91%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041803 | Exenatide | ASY | ASY-{CAT}-2827 | Medutest | 2026-Q2 | 99.61 | 4.99 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043435 | TB-500 | WXT | WXT-2507-J4054 | Medutest | 2025-Q4 | 97.83 | 3.03 | 102.6 | Buyer-sourced | 0 | FAIL |
| AX-2025-020026 | Semaglutide | SWB | SWB-2511-B7324 | Janoshik | 2025-Q4 | 98.07 | 5.25 | 101.8 | Buyer-sourced | 0 | PASS |
| AX-2025-021123 | Retatrutide | SIG | SIG-2508-6037 | Kestrel | 2025-Q3 | 97.97 | 2.82 | 91.9 | Buyer-sourced | 0 | PASS |
| AX-2025-020413 | Liraglutide | MKM | MKM-2508-P4928 | Janoshik | 2025-Q3 | 97.87 | 7.04 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020776 | SS-31 (Elamipretide) | CPC | CPC-2504-E9752 | Medutest | 2025-Q3 | 99.82 | 5.27 | 93.2 | Buyer-sourced | 0 | PASS |
| AX-2025-020620 | MK-677 (Ibutamoren mesylate) | GL Biochem | GLBI-2501-Y7989 | PeptideMeter | 2025-Q2 | 98.82 | 4.94 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019181 | BPC-157 | SinoPep | SNP-2501-E3910 | Janoshik | 2025-Q2 | 99.57 | 3.53 | 96.5 | Buyer-sourced | 0 | PASS |
| AX-2025-021134 | Epitalon | SIG | SIG-2412-6325 | Janoshik | 2025-Q1 | 99.01 | 8.56 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004125 | Semax | WWB | WWB-2308-N1754 | Janoshik | 2024-Q1 | 99.76 | 5.00 | 94.2 | Buyer-sourced | 0 | PASS |